← Back to Search

Behavioural Intervention

Chiropractic Care for Back Pain (ACCESS-DC Trial)

N/A
Waitlist Available
Led By Peter C Emary, DC, PhD
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Individuals already receiving chiropractic care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-, 12-, 18- and 26-week follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if chiropractic care added to usual medical care helps reduce opioid use in communities with high rates of chronic musculoskeletal pain and opioid use.

Who is the study for?
This trial is for adults in Ontario with chronic non-cancer spinal pain who have been on opioids for at least 3 months and are interested in reducing their opioid use. They must be able to understand the study and give informed consent. People already getting chiropractic care, using low-dose opioids, treated for opioid misuse, or with certain serious spine conditions can't join.
What is being tested?
The study tests if adding chiropractic care to usual medical treatments helps reduce opioid use more than usual medical treatments alone. It's a pilot randomized controlled trial conducted at community health centers serving high-need areas.
What are the potential side effects?
While not explicitly stated, side effects may include typical reactions to chiropractic adjustments such as temporary soreness or discomfort. Usual medical care side effects depend on the specific treatments received.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving chiropractic treatments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-, 12-, 18- and 26-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-, 12-, 18- and 26-week follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Compliance with the Protocol
Participant Enrolment
Refinement of Data Collection Methods
+1 more
Secondary study objectives
Daily Prescribed Opioid Dosage
Level of Bothersomeness of Spinal Pain
Level of Pain Intensity, and Physical and Emotional Functioning as measured by the Bournemouth Questionnaire (BQ)
+4 more
Other study objectives
Number of Participants Experiencing Treatment-Related Adverse Events

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Medical Care + Chiropractic CareExperimental Treatment1 Intervention
This group will consist of eligible, consenting, participants attending centers randomized to ongoing usual medical care plus chiropractic care.
Group II: Usual Medical CareActive Control1 Intervention
This group will consist of eligible, consenting, participants attending centers randomized to ongoing usual medical care.

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,392 Previous Clinical Trials
26,529,420 Total Patients Enrolled
5 Trials studying Back Pain
2,251 Patients Enrolled for Back Pain
Canadian Chiropractic Research FoundationUNKNOWN
1 Previous Clinical Trials
240 Total Patients Enrolled
Ontario Chiropractic AssociationUNKNOWN
Alliance for Healthier CommunitiesUNKNOWN
Surgical Methods Centre, McMaster UniversityUNKNOWN
McMaster UniversityLead Sponsor
917 Previous Clinical Trials
2,616,228 Total Patients Enrolled
10 Trials studying Back Pain
990 Patients Enrolled for Back Pain
Michael G. DeGroote Institute for Pain Research and CareUNKNOWN
Michael G. DeGroote National Pain CentreUNKNOWN
Peter C Emary, DC, PhDPrincipal InvestigatorMcMaster University
Jason W Busse, DC, PhDStudy DirectorMcMaster University
1 Previous Clinical Trials
40 Total Patients Enrolled
~17 spots leftby Sep 2025